Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors

The International Journal of Biochemistry & Cell Biology
Hugo R AriasC Bouzat

Abstract

Nicotinic acetylcholine receptors are pentameric proteins that belong to the Cys-loop receptor superfamily. Their essential mechanism of functioning is to couple neurotransmitter binding, which occurs at the extracellular domain, to the opening of the membrane-spanning cation channel. The function of these receptors can be modulated by structurally different compounds called noncompetitive antagonists. Noncompetitive antagonists may act at least by two different mechanisms: a steric and/or an allosteric mechanism. The simplest idea representing a steric mechanism is that the antagonist molecule physically blocks the ion channel. On the other hand, there exist distinct allosteric mechanisms. For example, noncompetitive antagonists may bind to the receptor and stabilize a nonconducting conformational state (e.g., resting or desensitized state), and/or increase the receptor desensitization rate. Barbiturates, dissociative anesthetics, antidepressants, and neurosteroids have been shown to inhibit nicotinic receptors by allosteric mechanisms and/or by open- and closed-channel blockade. Receptor modulation has proved to be highly complex for most noncompetitive antagonists. Noncompetitive antagonists may act by more than one mechanis...Continue Reading

References

May 1, 1978·European Journal of Pharmacology·S RyderA J Trevor
Oct 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S ValeraD Bertrand
Nov 1, 1990·British Journal of Pharmacology·B A DodsonK W Miller
Jan 1, 1991·Annals of the New York Academy of Sciences·R J LeonardH A Lester
Jun 15, 1987·Biochemical and Biophysical Research Communications·R MosckovitzM Sokolovsky
Feb 1, 1985·British Journal of Anaesthesia·P F WhiteA J Trevor
Mar 12, 1982·European Journal of Pharmacology·R S AronstamD A Wenger
Aug 1, 1993·Current Opinion in Cell Biology·D BertrandJ P Changeux
Mar 1, 1995·Trends in Neurosciences·M O Ortells, G G Lunt
Jan 1, 1995·Annual Review of Physiology·D S McGehee, L W Role
Jun 1, 1993·Current Opinion in Neurobiology·A Karlin
Apr 1, 1996·Neuropharmacology·C A Briggs, D G McKenna
Mar 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·J García-ColungaR Miledi
Mar 1, 1996·Trends in Neurosciences·M V Jones, G L Westbrook
Mar 1, 1997·The Journal of General Physiology·J P DilgerA M Vidal
Sep 18, 1997·Trends in Neurosciences·G M Shepherd, S D Erulkar
Aug 5, 1998·The Journal of General Physiology·A Auerbach, G Akk

❮ Previous
Next ❯

Citations

Sep 13, 2011·Journal of Medicinal Chemistry·Nadezhda GermanRichard A Glennon
Nov 6, 2012·Journal of Medicinal Chemistry·Sharan K BagalNigel A Swain
Sep 2, 2009·Nature Reviews. Drug Discovery·Antoine TalyJean-Pierre Changeux
Jun 1, 2011·The Journal of General Physiology·Wai-Fung WongEdgar C Young
May 18, 2010·Assay and Drug Development Technologies·Scott C MayerMark R Bowlby
Jul 2, 2011·Biological & Pharmaceutical Bulletin·Qing-Zhong LiKi-Wug Sung
May 30, 2008·Frontiers in Bioscience : a Journal and Virtual Library·Gregg B Wells
Jul 7, 2015·Future Medicinal Chemistry·Marco Atzori, Manuel Mejia
Oct 15, 2011·Journal of Physiology, Paris·Cecilia Bouzat
Jun 7, 2011·The International Journal of Biochemistry & Cell Biology·Hugo R AriasKrzysztof Jozwiak
Jul 17, 2010·Neuropharmacology·Galya R AbdrakhmanovaF Ivy Carroll
Jul 14, 2010·Pharmacology & Therapeutics·Jutta WalstabBeate Niesler
Jun 10, 2009·Frontiers in Neuroendocrinology·Jean Luc Do RegoHubert Vaudry
Apr 30, 2009·The International Journal of Biochemistry & Cell Biology·Hugo R AriasShaker A Mousa
Mar 4, 2008·European Journal of Pharmacology·Fernanda Gumilar, Cecilia Bouzat
May 9, 2009·British Journal of Pharmacology·Guillermo SpitzmaulCecilia Bouzat
Jan 29, 2013·Genes, Brain, and Behavior·H M KamensM A Ehringer
Feb 24, 2011·Bioelectromagnetics·María Fernanda TolosaWalter Rubén Cravero
May 21, 2011·Biochemical Pharmacology·Anshul Pandya, Jerrel L Yakel
Mar 17, 2010·Chemico-biological Interactions·Klara Bulc RozmanDusan Suput
Jul 28, 2011·Neuropharmacology·Jesús García-ColungaElizabeth Vázquez-Gómez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.